Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins.

Smagris E, Gilyard S, BasuRay S, Cohen JC, Hobbs HH.

J Biol Chem. 2016 May 13;291(20):10659-76. doi: 10.1074/jbc.M116.719955. Epub 2016 Mar 24.

2.

Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.

Kahali B, Halligan B, Speliotes EK.

Semin Liver Dis. 2015 Nov;35(4):375-91. doi: 10.1055/s-0035-1567870. Epub 2015 Dec 16.

3.

Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico.

Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A.

World J Gastroenterol. 2015 Nov 7;21(41):11552-66. doi: 10.3748/wjg.v21.i41.11552. Review.

4.

Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.

Dongiovanni P, Romeo S, Valenti L.

Biomed Res Int. 2015;2015:460190. doi: 10.1155/2015/460190. Epub 2015 Jul 27. Review.

5.

Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.

Zhang S, Wu H, Wu X, Lian W, Wang Y, Zhang X, Peng X.

Int J Clin Exp Med. 2015 May 15;8(5):6638-49. eCollection 2015. Review.

6.

PNPLA3 genetic variation in alcoholic steatosis and liver disease progression.

Stickel F, Hampe J, Trépo E, Datz C, Romeo S.

Hepatobiliary Surg Nutr. 2015 Jun;4(3):152-60. doi: 10.3978/j.issn.2304-3881.2014.11.04. Review.

7.

Association of PNPLA3 I148M Variant With Chronic Viral Hepatitis, Autoimmune Liver Diseases and Outcomes of Liver Transplantation.

Geng N, Xin YN, Xia HH, Jiang M, Wang J, Liu Y, Chen LZ, Xuan SY.

Hepat Mon. 2015 Apr 25;15(4):e26459. doi: 10.5812/hepatmon.15(4)2015.26459. eCollection 2015 Apr. Review.

8.

The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis.

Shen JH, Li YL, Li D, Wang NN, Jing L, Huang YH.

J Lipid Res. 2015 Jan;56(1):167-75. doi: 10.1194/jlr.M048777. Epub 2014 Nov 5.

9.

Correlation between patatin-like phospholipase domain-containing protein 3 gene polymorphisms and liver cirrhosis in a chinese han population with chronic hepatitis B.

Tong J, Guo J, Hu J, Hou S, Zhang Y, Li Q.

Hepat Mon. 2014 Aug 17;14(8):e18943. doi: 10.5812/hepatmon.18943. eCollection 2014 Aug.

10.

Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Dongiovanni P, Romeo S, Valenti L.

World J Gastroenterol. 2014 Sep 28;20(36):12945-55. doi: 10.3748/wjg.v20.i36.12945. Review.

11.

PNPLA3 I148M polymorphism and progressive liver disease.

Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valenti L.

World J Gastroenterol. 2013 Nov 7;19(41):6969-78. doi: 10.3748/wjg.v19.i41.6969. Review.

12.

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.

Valenti L, Motta BM, Soardo G, Iavarone M, Donati B, Sangiovanni A, Carnelutti A, Dongiovanni P, Rametta R, Bertelli C, Facchetti F, Colombo M, Fargion S, Fracanzani AL.

PLoS One. 2013 Oct 14;8(10):e75982. doi: 10.1371/journal.pone.0075982. eCollection 2013.

13.

Identification of combined genetic determinants of liver stiffness within the SREBP1c-PNPLA3 pathway.

Krawczyk M, Grünhage F, Lammert F.

Int J Mol Sci. 2013 Oct 22;14(10):21153-66. doi: 10.3390/ijms141021153.

14.

PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.

Burza MA, Molinaro A, Attilia ML, Rotondo C, Attilia F, Ceccanti M, Ferri F, Maldarelli F, Maffongelli A, De Santis A, Attili AF, Romeo S, Ginanni Corradini S.

Liver Int. 2014 Apr;34(4):514-20. doi: 10.1111/liv.12310. Epub 2013 Sep 19.

15.

Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.

Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D.

Mol Carcinog. 2013 Nov;52 Suppl 1:E139-47. doi: 10.1002/mc.22057. Epub 2013 Jun 15.

16.
17.

PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease.

Sookoian S, Pirola CJ.

World J Gastroenterol. 2012 Nov 14;18(42):6018-26. doi: 10.3748/wjg.v18.i42.6018.

18.

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.

Li JZ, Huang Y, Karaman R, Ivanova PT, Brown HA, Roddy T, Castro-Perez J, Cohen JC, Hobbs HH.

J Clin Invest. 2012 Nov;122(11):4130-44.

19.

The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.

Nischalke HD, Berger C, Luda C, Berg T, Müller T, Grünhage F, Lammert F, Coenen M, Krämer B, Körner C, Vidovic N, Oldenburg J, Nattermann J, Sauerbruch T, Spengler U.

PLoS One. 2011;6(11):e27087. doi: 10.1371/journal.pone.0027087. Epub 2011 Nov 7.

20.

Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease.

Huang Y, Cohen JC, Hobbs HH.

J Biol Chem. 2011 Oct 28;286(43):37085-93. doi: 10.1074/jbc.M111.290114. Epub 2011 Aug 30.

Items per page

Supplemental Content

Write to the Help Desk